Work

CD14+HLA-DRlow/− expression: A novel prognostic factor in chronic lymphocytic leukemia

Year: 2014
Type: article
Study design: Observational Study
Abstract: Currently, no prognostic factors exist for determining the host immune status of chronic lymphocytic leukemia (CLL) patients. Therefore, the present report analyzed cluster of differentiation 14 (CD14)+ human leukocyte antigen (HLA)‑DRlow/‑ myeloid‑derived suppressor cells (MDSC) from 49 CLL patients and demonstrated that these cells were significantly expanded in all CLL patients when compared with monoclonal B cell lymphocytosis patients and healthy volunteers. Furthermore, upregulation of CD14+HLA‑DRlow/‑ MDSCs was correlated with CLL tumor progression and a poor prognosis for CLL patients, and CD14+HLA‑DRlow/‑ MDSCs were significantly correlated with the presence of CD4+ T and CD5+CD19+ cells in CLL patients, which could significantly inhibit the CD4+ T‑cell immune response, contributing to CLL cell progression in CLL patients.
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: diamond
OpenAlex ID: W2000607002
FWCI: 2.284
Cites: 14
Cited by: 41
Related to: 10